D15 - The Cost of Not Knowing- How Early Detection of Diabetes Impacts Distress

Sunday, August 10, 2025

11:00 AM - 11:45 AM MST

CE/CME Hours: .75 CE

Prevalence of DKA at or near T1D diagnosis has increased over time. Overall health implications have long been established regarding DKA, but what are the emotional, social, and economic costs of being diagnosed in crisis? Learn about the national Cost of Not Knowing survey completed in March 2024 and how early detection of T1D can decrease overall distress.

Disclosure(s):

Melanie Batchelor, MHS, RD, LDN, CDCES: No financial relationships to disclose

Mariana Gomez, MBA: No financial relationships to disclose

Primary Presenter(s)

Melanie Batchelor, MHS, RD, LDN, CDCES

Health Impact Manager
Beyond Type 1
Clyde, North Carolina

Disclosure(s): No financial relationships to disclose

Co-Presenter(s)

Mariana Gomez, MBA (she/her/hers)

VP of International Markets
Beyond Type 1
Granada Hills, California

Disclosure(s): No financial relationships to disclose

Session Host(s)

Sneha Srivastava, PharmD, BCACP, DIPACLM, CDCES, FADCES (she/her/hers)

Associate Director of Skills Education and Clinical Pharmacist
Rosalind Franklin University of Medicine and Scien
North Chicago, Illinois

Disclosure information not submitted.